Lenskart is seeing strong traction from Tier II and beyond towns. Rocket Health brings therapy, psychiatry, diagnosis, and ...
Alphabet's fair value estimate has increased slightly, with the price target rising from $318.24 to $323.70 per share. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback